Cambridge, MA: Cognito Tx is developing Spectris, a non-invasive, at-home therapy in Phase 3 trials, designed to stimulate brain waves and potentially preserve cognition in Alzheimer’s disease.

Scripta Therapeutics: AI-Powered Drug Discovery for Neurodegenerative Diseases

Therini Bio: Fibrin-Targeted Therapies for Neurological and Retinal Diseases

BioNYRA Pharma: Next-Generation Antibody Therapies for Immune-Mediated Inflammatory Diseases

Auron Announces First Patient Dosed in Phase 1 Clinical Trial of AUTX-703 in Advanced Hematologic Malignancies

Therini Bio Raises Additional $39M Series A Financing to Advance Clinical Development of Neurodegenerative Disease Pipeline

HAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases

Auron Therapeutics Announces AUTX-703 Granted Fast Track Designation by the FDA for Relapsed or Refractory Acute Myelogenous Leukemia